Medicine guide

EXFORGE HCT

As listed in the register: EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

160 mg / 5 mg / 25 mg · comprimido recubierto con película

Prescription only
Heart, blood pressure and circulation

Active substance: Valsartán + amlodipino + hidroclorotiazida
Used in: Heart, blood pressure and circulation
Made by: Novartis Europharm Limited
Source: Official label

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupHeart, blood pressure and circulationC09DX01

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

Every strength and form (96)

European UnionNo exact match for this strength and form

Every strength and form (4)

NetherlandsNo exact match for this strength and form

Every strength and form (42)

SwitzerlandNo exact match for this strength and form

Every strength and form (16)

Details

Made by	Novartis Europharm Limited
Active substance	Valsartán + amlodipino + hidroclorotiazida
Used in	Heart, blood pressure and circulation
Strength	160 mg / 5 mg / 25 mg
Form	comprimido recubierto con película
Classification	C09DX01 · Heart, blood pressure and circulation
Route	vía oral
Marketed	Yes, according to the register
Name in the register	EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Nº Registro	09569026

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.

Report wrong or outdated information on this page

Other strengths and forms

5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

comprimido recubierto con película5 products
- 10 mg/ 320 mg/ 25 MG
- 160 mg / 5 mg / 25 mg
- 160 mg / 12,5 mg / 10 mg
- 160 mg / 25 mg / 10 mg
- 160 mg / 12,5 mg / 5 mg

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.

AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA10 mg/160 mg/12,5 mgPrescription onlycomprimido recubierto con película Laboratorios Cinfa S.A. · Valsartán + amlodipino + hidroclorotiazida · C09DX01 AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA10 mg/ 160 mg/ 25 mgPrescription onlycomprimido recubierto con película Laboratorios Cinfa S.A. · Valsartán + amlodipino + hidroclorotiazida · C09DX01 AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA5 mg/160 mg/12,5 mgPrescription onlycomprimido recubierto con película Laboratorios Cinfa S.A. · Valsartán + amlodipino + hidroclorotiazida · C09DX01 AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA5 mg/160 mg/ 25 mgPrescription onlycomprimido recubierto con película Laboratorios Cinfa S.A. · Valsartán + amlodipino + hidroclorotiazida · C09DX01 AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFAMED10 mg/160 mg/25 mgPrescription onlycomprimido recubierto con película Laboratorios Cinfa S.A. · Valsartán + amlodipino + hidroclorotiazida · C09DX01 AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFAMED10 MG/320 MG /25 MGPrescription onlycomprimido recubierto con película Laboratorios Cinfa S.A. · Valsartán + amlodipino + hidroclorotiazida · C09DX01

See every product with Valsartán + amlodipino + hidroclorotiazida